Literature DB >> 13149890

Heparin and ethyl biscoum-acetate in prevention of experimental venous thrombosis.

P JEWELL, T PILKINGTON, B ROBINSON.   

Abstract

Entities:  

Keywords:  COUMARIN/derivatives; HEPARIN/effects; THROMBOSIS/experimental

Mesh:

Substances:

Year:  1954        PMID: 13149890      PMCID: PMC2084984          DOI: 10.1136/bmj.1.4869.1013

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Recanalization of thrombosed arteries under anticoagulant therapy.

Authors:  H P WRIGHT; M M KUBIK; M HAYDEN
Journal:  Br Med J       Date:  1953-05-09

2.  The Prevention of Experimental Thrombosis by Dicoumarin.

Authors:  D U Dale; L B Jaques
Journal:  Can Med Assoc J       Date:  1942-06       Impact factor: 8.262

3.  [Arterial thromboses treated by a new coagulant of the coumarin group].

Authors:  Z REINIS
Journal:  Presse Med       Date:  1950-04-26       Impact factor: 1.228

  3 in total
  6 in total

1.  The effect of phenindione on rats fed diets which produce thrombosis or experimental atherosclerosis.

Authors:  E DAVIDSON; A N HOWARD; G A GRESHAM
Journal:  Br J Exp Pathol       Date:  1962-08

2.  Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation.

Authors:  L C CAREY; R D WILLIAMS
Journal:  Ann Surg       Date:  1960-11       Impact factor: 12.969

3.  Studies in the production of standard venous thrombosis.

Authors:  R D WILLIAMS; L C CAREY
Journal:  Ann Surg       Date:  1959-03       Impact factor: 12.969

4.  Heparin and sympathetic block in treatment of venous thrombosis; experimental investigations.

Authors:  W RUDOWSKI
Journal:  Br Med J       Date:  1957-03-16

5.  An evaluation of long-term anticoagulant therapy.

Authors:  M M SUZMAN
Journal:  Postgrad Med J       Date:  1956-04       Impact factor: 2.401

6.  Anticoagulants in coronary disease.

Authors:  A R GILCHRIST; J A TULLOCH
Journal:  Br Med J       Date:  1954-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.